Skinbiotherapeutics Share Discussion Threads

[mshilos] 16/8/2018 12:46

I agree Matt...SP will fall as a result of what you say.

[mshilos] 16/8/2018 12:44

I agree 100 %. No trials next month..RNS to confirm. share price will drop below 19p doon ..even lower in weeks..back to 16p or lower IMHO.

[matt123d] 16/8/2018 12:43

The problem is the fall from the recent high without a quick bounce back from the 22/23p level has picked up investors now in losing positions. Either a large amount of fresh demand comes in or it goes lower to shake the losers out and meet the demand at a lower level, both of which take time.

[mshilos] 16/8/2018 12:42

I was referring to the 16 p April 7th 2017 price at launch.

[jamjason] 16/8/2018 12:40

If the trial was going ahead as planned next month, I doubt Andrew McBain and Manc University would have sold recently. That is my opinion.

[manc10] 16/8/2018 12:40

mshilos the ipo price was 9p

[mshilos] 16/8/2018 12:37

Opinions matter....why else are you on here ? share price has to fall until we have positive trial results...16 p or close to. Watch the drop over the coming weeks.DYOR.

[2350220] 16/8/2018 12:27

Mshilos, yet another expert who has suddenly got a profile a couple of weeks ago, offering such amazing insight.
Filtered.
John

[mshilos] 16/8/2018 12:18

I ztand by my opinion that the clinical trial will now have to be delayed and there will need to be an RNS to confirm this once they know when it will take place. The share price will fall to the initial April 2017 price or lower until we have trial results. This is still in its infancy and far far away from a profit generating business but the potential is huge hence the recent share price price rise based on sentiment and potential alone. This RNS is not good news...kt will drop more ...IMO. DYOR.

[belgrano2] 16/8/2018 12:10

Seems like the RNS was poorly worded and has caused at least one major player to decide to take profit now by dumping onto the market at least 700K shares. Seems investors are grabbing what they can while they can with a lot of buys going through currently and few associated sells. How many are being sold remains to be seen, but many are taking full advantage today at these cheap prices.

[rayrac] 16/8/2018 11:55

Days, weeks or months? Whatever next!

[judijudi] 16/8/2018 11:47

Thing is at UKOG
You aint got one, as its a Duster!!
:)

[rayrac] 16/8/2018 11:31

new sales channels, some big opportunities in retail and pharma that we need to conclude successfully, and a strategy which will return dividends to shareholders at the right opportunity. Summer is always slow and volatile as volumes tail off but we are developing a lot of opportunities which will hopefully come to fruition and be announceable in the coming days, weeks, or months."

Hopefully? Could be an escape route!

[rafboy] 16/8/2018 11:24

Yes, it’s a buy from earlier. Good to see.

[manc10] 16/8/2018 11:20

there was a trade at 97500 it is a buy not a sell

[siennadelekat21] 16/8/2018 11:17

I guess the coming weeks will confirm Whether you're correct or not Mshilos: )

[riskybusiness1] 16/8/2018 11:17

Take advantage today of an overly cautious RNS. Biggest risk was the upscale which has been successful. Thank you for the cheaper shares.

[rafboy] 16/8/2018 10:58

Mshilos, if the trial were being delayed they would have had to say so in the RNS. They haven’t and they would certainly know by now if it was going to. I suggest you may be wrong this time around.

[manc10] 16/8/2018 10:48

you will probably go over to opti next to trash that nobody is bothered or interested what you say soh told the truth not a no mark like you

[mshilos] 16/8/2018 10:40

What do I know ?? Seeing as you asked, I work for a biotech company, as a patent expert. This will delay the trials by another 8-12 weeks minimum DYOR

[primal123] 16/8/2018 10:37

Link for what?

[montynj] 16/8/2018 10:35

Hence today's fall is classic case of derampers misleading other investors. The bull case is firmly intact

[montynj] 16/8/2018 10:33

Comment from elrico on his google bb:Further comment from SOH after I suggested the great news on manufaturing scale up was killed by what investors perceived as bad news (24/hr shelf life and further work) appeared to suggest this was a concern, only mitigated by the ability to freeze dry. Also comment on OPTI."The SBTX RNS is a very positive RNS . Manufacturing scale up was the biggest risk and this has been achieved with a partner!!. Also the ability to freeze dry is a major step forward as that gives you extended shelf life for the SkinBiotix technology which is key for partners looking to incorporate this sort of ingredient into products.  Product stability is typically a matter of formulation once your lysate is stable.  The RNS doesn't say the cream is not stable for longer than 24 hours.  Its says they have tested it for 24 hours and they are now testing for longer in preparation for the studies.  This is all part of the development process and they are updating investors as to this process."OPTI"My view remains more balanced in that Opti has had a good run and is in a strong position with a good pipeline of deal flow, new sales channels, some big opportunities in retail and pharma that we need to conclude successfully, and a strategy which will return dividends to shareholders at the right opportunity.  Summer is always slow and volatile as volumes tail off but we are developing a lot of opportunities which will hopefully come to fruition and be announceable in the coming days, weeks, or months."

[manc10] 16/8/2018 10:33

mishilos what do you know you have only done 3 posts all negative about sbtx let the scientists do there job not the speculators filtered